pmc logo image
Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells
Anne Camirand, Mahvash Zakikhani, Fiona Young, Michael Pollak
Breast Cancer Res. 2005; 7(4): R570–R579. Published online 2005 April 12. doi: 10.1186/bcr1028
PMCID:
PMC1175059
Abstract Full Text PDF–700K
 Is Cited by the Following 9 Articles in this Archive:
A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis
Robert K Dearth, Isere Kuiatse, Yu-Fen Wang, Lan Liao, Susan G Hilsenbeck, Powel H Brown, Jianming Xu, Adrian V Lee
BMC Cancer. 2011; 11: 377. Published online 2011 August 25. doi: 10.1186/1471-2407-11-377
PMCID:
PMC3189189
Abstract Full Text PDF–827K
Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer
Lisa A. Elferink, Vicente A. Resto
J Signal Transduct. 2011; 2011: 982879. Published online 2011 June 7. doi: 10.1155/2011/982879
PMCID:
PMC3135278
Abstract Full Text PDF–660K
Dual Inhibition of Epidermal Growth Factor Receptor and Insulin-like Growth Factor Receptor I Reduces Angiogenesis and Tumor Growth in Cutaneous Squamous Cell Carcinoma
Chad E. Galer, Christina L. Corey, Zhuoying Wang, Maher N. Younes, Fernando Gomez-Rivera, Samar A. Jasser, Dale L. Ludwig, Adel K. El-Naggar, Randal S. Weber, Jeffrey N. Myers
Head Neck. Author manuscript; available in PMC 2012 February 1.
Published in final edited form as: Head Neck. 2011 February; 33(2): 189–198. doi: 10.1002/hed.21419
PMCID:
PMC3010504
Abstract Full Text PDF–605K
A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors
Dana Inbar-Rozensal, Asher Castiel, Leonid Visochek, David Castel, Françoise Dantzer, Shai Izraeli, Malka Cohen-Armon
Breast Cancer Res. 2009; 11(6): R78. Published online 2009 November 9. doi: 10.1186/bcr2445
PMCID:
PMC2815540
Abstract Full Text PDF–3.7M Supplementary Material
Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach
Rongshi Li, Alan Pourpak, Stephan W. Morris
J Med Chem. Author manuscript; available in PMC 2010 August 1.
Published in final edited form as: J Med Chem. 2009 August 27; 52(16): 4981–5004. doi: 10.1021/jm9002395
PMCID:
PMC2888655
Full Text PDF–413K
Cixutumumab
Kevin P McKian, Paul Haluska
Expert Opin Investig Drugs. Author manuscript; available in PMC 2010 September 15.
Published in final edited form as: Expert Opin Investig Drugs. 2009 July; 18(7): 1025–1033. doi: 10.1517/13543780903055049
PMCID:
PMC2939377
Abstract Full Text PDF–910K
Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation
Julie L. Wilsbacher, Qian Zhang, Lora A. Tucker, Robert D. Hubbard, George S. Sheppard, Nwe Y. Bamaung, Steve D. Fidanze, Gary T. Wang, Xiaoming Hu, Steven K. Davidsen, Randy L. Bell, Jieyi Wang
J Biol Chem. 2008 August 29; 283(35): 23721–23730. doi: 10.1074/jbc.M708360200
PMCID:
PMC3259780
Abstract Full Text
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer
Joanna Lisztwan, Astrid Pornon, Bin Chen, Shiuan Chen, Dean B Evans
Breast Cancer Res. 2008; 10(4): R56. Published online 2008 July 8. doi: 10.1186/bcr2113
PMCID:
PMC2575527
Abstract Full Text PDF–1.1M Supplementary Material
Mechanisms of resistance to ErbB-targeted cancer therapeutics
Qiang Wang, Mark I. Greene
J Clin Invest. 2008 July 1; 118(7): 2389–2392. Published online 2008 June 20. doi: 10.1172/JCI36260
PMCID:
PMC2430503
Abstract Full Text PDF–312K
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk